Please login to the form below
Free Thinking: Are biosimilars the answer to the rising cost of RA treatment?
In a past Free Thinking paper, we looked at the opportunity and challenges for biosimilar mAbs entering the rheumatoid arthritis market. A few years later and according to our Therapy Watch patient record data, uptake of biosimilars remains relatively muted, with marked inconsistencies across the major European markets. With Enbrel biosimilar Benepali about to launch across EU, we ask what’s next for RA?
http://www.researchpartnership.com/news/2016/04/ft-are-biosimilars-the-answer-to-the-rising-cost-of-...
Company Details
Research Partnership
+44 (0)20 8069 5000
Address:
Chester House
Fulham Green
81-83 Fulham High Street
London
SW6 3JW
United Kingdom
Latest content on this profile
- Article: Engaging patient advocacy groups
- The key to conducting effective rare disease research
Research Partnership
- Webcast: Harnessing the power of social: How to generate fresh insights for your business using social media listening
Research Partnership
- Article: Like, Like, Like: Harnessing the power of social media insights
Research Partnership
- Infographic: China: How to keep up and win in the world's fastest changing healthcare market
Research Partnership
- Article: New Hopes for Mexico: What will be the future of healthcare under the country's new administration?
Research Partnership
- Event: Richard Head presented with MR Excellence award at EphMRA Conference
Research Partnership
